# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-207572
Filing Date
2026-05-06
Accepted
2026-05-06 07:30:34
Documents
54
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tcrx-20260331.htm iXBRL | 10-Q | 2145505
2 | EX-31.1 | tcrx-ex31_1.htm | EX-31.1 | 23639
3 | EX-31.2 | tcrx-ex31_2.htm | EX-31.2 | 23657
4 | EX-32.1 | tcrx-ex32_1.htm | EX-32.1 | 9864
5 | EX-32.2 | tcrx-ex32_2.htm | EX-32.2 | 10979
| Complete submission text file | 0001193125-26-207572.txt |  | 6701513

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | tcrx-20260331.xsd | EX-101.SCH | 1050512
58 | EXTRACTED XBRL INSTANCE DOCUMENT | tcrx-20260331_htm.xml | XML | 729432

Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40603 | Film No.: 26945823
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)